Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
November 6, 2017
Achaogen to Present at the Stifel 2017 Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Nov. 06, 2017 (GLOBE NEWSWIRE) -- Achaogen, Inc. (AKAO), a late-stage biopharmaceutical company developing innovative antibacterials addressing multi-drug resistant (MDR) gram-negative ...
November 6, 2017
Heron Therapeutics Reports Financial Results for the Three and Nine Months Ended September 30, 2017 and Recent Corporate Progress
SAN DIEGO, Calif.--(BUSINESS WIRE)--Heron Therapeutics, Inc. (HRTX) (the Company or Heron), a commercial-stage biotechnology company focused on developing novel, best-in-class treatments to address some of ...
November 6, 2017
UroGen Pharma Announces First Patient Enrolled in Allergan Phase 2 Clinical Trial of RTGel™ in Combination with BOTOX® for the Treatment of Overactive Bladder
RA’ANANA, Israel and NEW YORK, Nov. 06, 2017 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (URGN), a clinical-stage biopharmaceutical company developing treatments to address unmet needs ...
November 6, 2017
Aimmune Therapeutics Announces Third Quarter 2017 Financial Results and Planned Retirement of CEO by the End of 2018
BRISBANE, Calif.--(BUSINESS WIRE)--Aimmune Therapeutics, Inc. (AIMT), a biopharmaceutical company developing treatments for life-threatening food allergies, today announced financial results for the quarter and nine months ...
November 6, 2017
Rexahn Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Corporate Update
ROCKVILLE, Md., Nov. 06, 2017 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American:RNN), a clinical stage biopharmaceutical company developing innovative therapeutics for the treatment of ...
November 2, 2017
For the First Time Ever, There Will be a Full Week Dedicated to Plasminogen Deficiency (PLGD) !
LAVAL, QC, Nov. 2, 2017 /PRNewswire/ - Prometic Life Sciences Inc. (PLI.TO) (PFSCF), ("Prometic") is pleased to invite you to participate in a full week of ...
November 2, 2017
Aeglea BioTherapeutics to Present Preclinical Data at 2017 Society for Immunotherapy of Cancer (SITC) Annual Meeting
AUSTIN, Texas, Nov. 02, 2017 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (AGLE), a biotechnology company committed to developing enzyme-based therapeutics in the field of amino ...
November 2, 2017
Basilea reports on commercial progress of antifungal Cresemba® in Europe
Basel, Switzerland, November 2, 2017 - Basilea Pharmaceutica Ltd. (BSLN.SW) announced today that its licensing partner Pfizer recently launched the antifungal drug Cresemba® (isavuconazole) in ...
November 2, 2017
Zealand reports royalty revenue for the third quarter of 2017
Copenhagen, November 2, 2017 - Zealand Pharma ("Zealand") reports Q3 2017 royalty revenue from Sanofi's sales of Lyxumia®/Adlyxin® (lixisenatide) of DKK 5.0 million/USD 0.8 million ...
November 2, 2017
AC Immune SA to Receive Milestone Payment for Anti-Tau Antibody Moving into Phase 2 Trial for Alzheimer's Disease
Lausanne, Switzerland, November 2, 2017 - AC Immune SA (ACIU), a Swiss-based, clinical stage biopharmaceutical company with a broad pipeline focused on neurodegenerative diseases, today ...
November 2, 2017
Aradigm Announces Third Quarter 2017 Financial Results
HAYWARD, Calif.--(BUSINESS WIRE)--Aradigm Corporation (ARDM) (the “Company”) today announced financial results for the third quarter and nine months ended September 30, 2017. ...
November 2, 2017
Bioblast Pharma Reports Third Quarter 2017 Financial Results
TEL AVIV, Israel, Nov. 02, 2017 (GLOBE NEWSWIRE) -- Bioblast Pharma Ltd. (ORPN), a clinical-stage, orphan disease-focused biotechnology company, today announced financial results for the ...
November 2, 2017
CytoSorbents to Report Q3 2017 Operating and Financial Results
MONMOUTH JUNCTION, N.J., Nov. 2, 2017 /PRNewswire/ -- CytoSorbents Corporation (CTSO), a critical care immunotherapy leader using blood purification to treat life-threatening injury and infection in ...
November 2, 2017
Catalyst Biosciences Reports Third Quarter 2017 Operating & Financial Results and Provides Corporate Update
SOUTH SAN FRANCISCO, Calif., Nov. 02, 2017 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (CBIO), today announced operating and financial results for the third quarter ended ...
November 2, 2017
VBI Vaccines Strengthens Board of Directors with Appointment of Ran Nussbaum
CAMBRIDGE, Mass., Nov. 02, 2017 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (VBIV) (VBV.TO) (VBI), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, ...
November 2, 2017
Altimmune to Announce Third Quarter 2017 Financial Results on November 9
GAITHERSBURG, Md., Nov. 02, 2017 (GLOBE NEWSWIRE) -- Altimmune, Inc. (ALT), a clinical-stage immunotherapeutics company, today announced that it will announce financial results for the ...
November 2, 2017
Arcturus Therapeutics to Host Key Opinion Leader Call on Advances in Delivery of Nucleic Acid Medicines on Tuesday, November 7
SAN DIEGO, Nov. 02, 2017 (GLOBE NEWSWIRE) -- Arcturus Therapeutics, Inc., a leading RNA medicines company, announced today that it will host a live R&D ...
November 2, 2017
Catalyst Biosciences Reports Third Quarter 2017 Operating & Financial Results and Provides Corporate Update
SOUTH SAN FRANCISCO, Calif., Nov. 02, 2017 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (CBIO), today announced operating and financial results for the third quarter ended ...
November 2, 2017
AIT Therapeutics Completes Treatment of Patient Infected with NTM abscessus at the National Institute of Health (NIH) with its Nitric Oxide (NO) Treatment
NEW YORK, Nov. 02, 2017 (GLOBE NEWSWIRE) -- AIT Therapeutics Inc. (AITB), a clinical-stage biopharmaceutical company focused on developing inhaled Nitric Oxide (NO) for the ...
November 2, 2017
UroGen Pharma Appoints Former Kite Pharma Chief Operating Officer Cynthia M. Butitta to its Board of Directors
RA’ANANA, Israel and NEW YORK, Nov. 02, 2017 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (URGN), a clinical-stage biopharmaceutical company developing treatments to address unmet needs ...
Page 81 of 117